Literature DB >> 21969055

Poorly differentiated thyroid carcinoma. Are we there yet?

Giovanni Tallini1.   

Abstract

The article reviews the controversial area of poorly differentiated thyroid carcinoma. Consensus criteria that define poorly differentiated thyroid carcinoma have been published in 2007. According to these, poorly differentiated thyroid carcinoma is a distinct histotype and the term "poorly differentiated" should not be used as a synonym for high-grade thyroid cancer. Data in the literature show that tumor necrosis and high mitotic activity, but not growth pattern or histologic subtype, are prognostic markers for thyroid tumors. This underscores the importance of grading to identify thyroid carcinomas that behave aggressively. The issue of grading versus typing thyroid tumors is discussed.

Entities:  

Mesh：

Year:  2011        PMID： 21969055     DOI： 10.1007/s12022-011-9176-5

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN： 1046-3976            Impact factor:   3.943


  32 in total

1.  Hail to the histologic grading of papillary thyroid carcinoma?

Authors:  M Sobrinho-Simões
Journal:  Cancer       Date:  2000-04-15       Impact factor: 6.860

2.  Poorly differentiated thyroid carcinoma--it is important.

Authors:  L A Akslen; V A LiVolsi
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

Review 3.  Poorly differentiated thyroid carcinoma: introduction to the issue, its landmarks, and clinical impact.

Authors:  Juan Rosai
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

4.  Poorly differentiated oxyphilic (Hurthle cell) carcinomas of the thyroid.

Authors:  M Papotti; B Torchio; L Grassi; A Favero; G Bussolati
Journal:  Am J Surg Pathol       Date:  1996-06       Impact factor: 6.394

5.  Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid.

Authors:  M Sobrinho-Simões; J M Nesland; J V Johannessen
Journal:  Am J Clin Pathol       Date:  1988-02       Impact factor: 2.493

6.  Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland.

Authors:  S Pilotti; P Collini; L Mariani; M Placucci; I Bongarzone; P Vigneri; S Cipriani; F Falcetta; R Miceli; M A Pierotti; F Rilke
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

7.  Poorly differentiated forms of papillary thyroid carcinoma: distinctive entities or morphological patterns?

Authors:  S Pilotti; P Collini; A Manzari; E Marubini; F Rilke
Journal:  Semin Diagn Pathol       Date:  1995-08       Impact factor: 3.464

8.  Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Authors:  Julio C Ricarte-Filho; Mabel Ryder; Dhananjay A Chitale; Michael Rivera; Adriana Heguy; Marc Ladanyi; Manickam Janakiraman; David Solit; Jeffrey A Knauf; R Michael Tuttle; Ronald A Ghossein; James A Fagin
Journal:  Cancer Res       Date:  2009-06-01       Impact factor: 12.701

9.  Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.

Authors:  Ronald A Ghossein; Rebecca Leboeuf; Kepal N Patel; Michael Rivera; Nora Katabi; Diane L Carlson; Giovanni Tallini; Ashok Shaha; Buvanesh Singh; R Michael Tuttle
Journal:  Thyroid       Date:  2007-07       Impact factor: 6.568

10.  Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study.

Authors:  Michael Rivera; Julio Ricarte-Filho; Snehal Patel; Michael Tuttle; Ashok Shaha; Jatin P Shah; James A Fagin; Ronald A Ghossein
Journal:  Hum Pathol       Date:  2009-11-13       Impact factor: 3.466
View more
  10 in total

1.  The neutrophil to lymphocyte ratio can discriminate anaplastic thyroid cancer against poorly or well differentiated cancer.

Authors:  Jin-Seong Cho; Min-Ho Park; Young-Jae Ryu; Jung-Han Yoon
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

2.  MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights.

Authors:  Matthias S Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  J Mol Endocrinol       Date:  2014-03-06       Impact factor: 5.098

3.  Primary high-grade non-anaplastic thyroid carcinoma: a retrospective study of 364 cases.

Authors:  Bin Xu; Julia David; Snjezana Dogan; Iñigo Landa; Nora Katabi; Maelle Saliba; Anjanie Khimraj; Eric J Sherman; Robert Michael Tuttle; Giovanni Tallini; Ian Ganly; James A Fagin; Ronald A Ghossein
Journal:  Histopathology       Date:  2021-10-07       Impact factor: 7.778

4.  Anaplastic Transformation of Papillary Thyroid Carcinoma in a Young Man: A Case Study with Immunohistochemical and BRAF Analysis.

Authors:  Ji Hye Park; Hyeong Ju Kwon; Cheong Soo Park; SoonWon Hong
Journal:  Korean J Pathol       Date:  2014-06-26

5.  Poorly differentiated thyroid carcinoma: an incubating entity.

Authors:  Peter M Sadow; William C Faquin
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-21       Impact factor: 5.555

6.  Nonanaplastic follicular cell-derived thyroid carcinoma: mitosis and necrosis in long-term follow-up.

Authors:  Daniel Bräuner Skansing; Stefano Christian Londero; Pia Asschenfeldt; Stine Rosenkilde Larsen; Christian Godballe
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-14       Impact factor: 2.503

Review 7.  Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?

Authors:  Marco Volante; Alfred K Lam; Mauro Papotti; Giovanni Tallini
Journal:  Endocr Pathol       Date:  2021-02-04       Impact factor: 3.943

8.  Clinical Efficacy of Levothyroxine Sodium plus I 131 in the Treatment of Patients with Thyroidectomy and Its Effect on the Levels of Thyroglobulin and Thyrotropin.

Authors:  Ya-Ling Pang; Yan-Ping Wang; Kun Cheng
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-02       Impact factor: 2.650

Review 9.  Data set for reporting carcinoma of the thyroid: recommendations from the International Collaboration on Cancer Reporting.

Authors:  Ronald Ghossein; Justine A Barletta; Martin Bullock; Sarah J Johnson; Kennichi Kakudo; Alfred K Lam; Mufaddal T Moonim; David N Poller; Giovanni Tallini; R Michael Tuttle; Bin Xu; Anthony J Gill
Journal:  Hum Pathol       Date:  2020-09-10       Impact factor: 3.466

10.  Poorly differentiated thyroid carcinoma: a retrospective clinicopathological study.

Authors:  Ghofrane Salhi Cherkaoui; Amal Guensi; Sara Taleb; Malika Ait Idir; Najwa Touil; Rita Benmoussa; Zaineb Baroudi; Nabil Chikhaoui
Journal:  Pan Afr Med J       Date:  2015-06-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.